Effect of different doses of gadolinium contrast agent on clinical outcomes in MS

OBJECTIVE: The objective of this paper is to evaluate potential dose-dependent adverse effects of gadolinium-based contrast agents (GBCAs) on MS progression. METHODS: Outcomes from a cohort of 612 secondary progressive MS (SPMS) patients, enrolled in a two-year, placebo-controlled (negative) trial a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mult Scler J Exp Transl Clin
Hlavní autoři: Ackermans, Nathalie, Taylor, Carolyn, Tam, Roger, Carruthers, Robert, Kolind, Shannon, Kang, Heejun, Freedman, Mark S, Li, David KB, Traboulsee, Anthony L
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378456/
https://ncbi.nlm.nih.gov/pubmed/30800415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318823796
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky